About US
Contact us
-
Pfizer cost-savings campaign reaches Ireland, where 100 production workers will lose jobsPfizer’s $3.5 billion cost-savings drive has made its way overseas. After job cuts hit several sites in the U.S., the pharma giantis reducing the headcount at one of its Irish manufacturing plants in2023/11/7
-
After scoring limited FDA nod, Sage and Biogen call an audible on pricing strategy for ZurzuvaeBefore Sage and Biogen’s Zurzuvae (zuranolone) won approval from the FDA for postpartum depression (PPD) in August, the companies had said that the highly anticipated first-in-class treatment would b2023/11/2
-
Sanofi stands behind 'accuracy of our accounts' amid reports of French manipulation probeSince launching the Regeneron-partneredantibody Dupixent in 2017, Sanofi has relied on the star medicine for sales growth.Now, though, an investigation in France calls into question some of the compa2023/11/2
-
WuXi XDC eyes $470.5M IPO to fuel manufacturing expansions at home and abroadWuXi's bioconjugation spinoffis set to break free onto the Hong Kong Stock Exchange this month, with plans to funnel hundreds of millions of dollars in proceeds back into its Asian manufacturing netw2023/10/31
-
With Amgen's biosim on the scene, J&J's Stelara looks poised to sidestep Medicare negotiations: HHSThere might just be a silver lining for Johnson & Johnson in the FDA's recent approval of Amgen’s Stelara biosimilar. That’s because the coming entry of a cheaper copycat presents J&J with an2023/10/31
-
Merck raises revenue guidance thanks to a surprising bump from COVID-19 pill LagevrioIt’s been grounded in Europe and reduced to irrelevancy in the U.S., but Merck’s COVID-19 pill Lagevrio somehow remains a force. The antiviral treatmentracked upsales of $640 million in the third qua2023/10/27
-
Bristol Myers' incoming CEO plots turnaround for struggling new launchesOn outgoing chief executive Giovanni Caforio’s last earnings call, Bristol Myers Squibb had some tough questions to answer about a roster of underperforming new products. But according to CEO-elect C2023/10/27
-
Amgen plans to lay off 350 former Horizon employees after $28B buyoutIn the biopharma industry, post-merger layoffs are often a question of when and how many. In the case of Amgen’s $27.8 billion buyout of Horizon, which wasrevealedlastDecember andfinalizedearlier thi2023/10/24
-
On heels of FDA approval, trial results set up GSK's RSV vaccine for label expansionFive months after becoming the first company to secure FDA approval for a respiratory syncytial virus (RSV) vaccine, GSK is taking steps toward expanding its label for Arexvy. On Wednesday, the compa2023/10/24
-
Roche condemns 'act of counterfeiting' as authorities in Pakistan crack down on unapproved Avastin useAfter several diabetic patients received a sham version of Roche's Avastin and lost their sight, the Drug Regulatory Authority of Pakistan (DRAP) is halting the sale or distribution of the drug until2023/10/19